Treatment of inflammatory bowel diseases through administration of enteric aerobization therapy
US11944641B2 · kind B2 · utility
3Cited by
10References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 4, 2022 |
| Grant date | Apr 2, 2024 |
| Priority date | — |
| Expiry date | Feb 4, 2042 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Agents, kits, and methods that utilize oxygenation to treat Inflammatory Bowel Disease (IBD) and/or provide prophylaxis against exacerbation of IBD are provided. In several embodiments, the agents, kits, and methods according to several embodiments generate in, or carry to, oxygen in the intestinal lumen to treat IBD and provide prophylaxis against exacerbation of IBD, including those caused by the presence of anaerobic bacteria in the intestine. The agents, kits, and methods provided herein generate an aerobic environment within the intestine to alleviate intestinal inflammation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.